Riskpilot← Back to searchSign inGet full accessMedizone Oy
OYActiveY-tunnus 3130213-2A -AGeneral medical practice activities · NACE 8621Est. 2020— employeeswww.medizone.fi
Revenue 2024
EUR 5,5M
-47% vs 2023
EBITDA margin
-0.2%
Equity ratio
63.3%
Financial strength
Net profit 2024
EUR -39K
-106% vs 2023
| Revenue | EUR 5,5M | -47% |
| EBITDA | EUR -13K | — |
| Net profit | EUR -39K | -106% |
| Total assets | EUR 1,2M | -46% |
| Equity | EUR 781K | -99% |
| Employees | — | — |
Legal name
Medizone Oy
Y-tunnus number
3130213-2
Legal form
Osakeyhtiö
NACE code
8621 · General medical practice activities
Founded
7. huhtikuuta 2020
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-10-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Terveyskeskus- ja vastaavat yleislääkäripalvelut
Address
A -A
Phone
+358453426691
Email
info@medizone.fi
Website
www.medizone.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 221 | 2 415 | 10 369 | 5 517 |
| Staff expenses | −110 | −1 984 | −6 694 | −1 831 |
| EBITDA | 39 | 202 | — | −13 |
| Depreciation & amort. | — | −3 | −5 | −15 |
| EBIT | 39 | 199 | 823 | −29 |
| Net financials | −0 | −5 | — | −1 |
| Profit before tax | 39 | 194 | — | −30 |
| Tax | 8 | 39 | 171 | 10 |
| Net profit | 31 | 155 | 650 | −39 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 85 | 681 | 2 291 | 1 234 |
| Equity | 31 | 183 | 83 272 | 781 |
| Long-term debt | — | — | 0 | 0 |
| Short-term debt | 54 | 498 | 145 779 | 452 |
| Total debt | 54 | 498 | 145 779 | 452 |
EBITDA margin
-0.2%
This company
15.8%
Market median
-101% vs market
20212024
Equity ratio
63.3%
This company
38.2%
Market median
+66% vs market
20212024
Return on equity
-5.0%
This company
18.4%
Market median
-127% vs market
20212024
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20212024
Asset turnover
4.47×
This company
1.12×
Market median
+299% vs market
20212024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20212024
- Annual report 2024Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-05-01 – 2023-10-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GA Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medizone Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Guled Ali Jama | Chief Executive Officer | 0 companies |
| Nawaad Mahad Abdirisaag | Board of Directors | 0 companies |
| Yoonis Ali Jama | Board of Directors | 0 companies |